Viewing Study NCT01142661

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 11:59 AM

Ignite Modification Date: 2025-12-28 @ 12:14 AM

Study NCT ID: NCT01142661

Status: COMPLETED

Last Update Posted: 2013-09-20

First Post: 2010-06-10

Is Gene Therapy: True

Has Adverse Events: True

Brief Title: Compassionate Use of Eribulin for the Treatment of Advanced Breast Cancer Refractory to All Other Marketed Therapies

Sponsor: Eisai Inc.

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module Adverse Events Module Baseline Characteristics Module Participant Flow Module